In vitro effects of antitumor antibody--chemotactic factor complexes.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000276:immunology*; D002234:Carbodiimides / Q000378:metabolism; D006528:Carcinoma, Hepatocellular / Q000276:immunology; D002630:Chemotactic Factors / Q000096:biosynthesis*; D003602:Cytotoxicity, Immunologic; D005260:Female; D006168:Guinea Pigs; D007074:Immunoglobulin G / Q000276:immunology / Q000378:metabolism; D016209:Interleukin-8; D008113:Liver Neoplasms; D008264:Macrophages; D008297:Male; D008715:Methionine / Q000031:analogs & derivatives*; D009239:N-Formylmethionine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D009240:N-Formylmethionine Leucyl-Phenylalanine; D009374:Neoplasms, Experimental / Q000276:immunology; D009842:Oligopeptides / Q000378:metabolism* / Q000494:pharmacology; D011817:Rabbits
D000912:Antibodies, Neoplasm; D002234:Carbodiimides; D002630:Chemotactic Factors; D007074:Immunoglobulin G; D016209:Interleukin-8; D009842:Oligopeptides; D009239:N-Formylmethionine; D009240:N-Formylmethionine Leucyl-Phenylalanine; D008715:Methionine